Home The Word Brain My Amedeo FAQ Privacy About   

2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.

  Prostate Cancer

  Free Subscription

Articles published in Hum Pathol

Retrieve available abstracts of 21 articles:
HTML format

Single Articles

    February 2024
  1. MAHLOW J, Barry M, Albertson DJ, Jo YJ, et al
    Histologic patterns in prostatic adenocarcinoma are not predictive of mutations in the homologous recombination repair pathway.
    Hum Pathol. 2024;144:28-33.
    PubMed     Abstract available

    January 2024
  2. BACHERT SE, Di J, Zhang S, Short HE, et al
    TRPS1 expression in primary and metastatic prostatic adenocarcinoma, muscle invasive bladder urothelial carcinoma, and breast carcinoma: Is TRPS1 truly specific and sensitive for a breast primary?
    Hum Pathol. 2024;143:42-49.
    PubMed     Abstract available

    December 2023
  3. DING Y, Bu P, Assylbekova B, Ruder S, et al
    Quantification of collagen content and stromal cellularity within reactive stroma is predictive of prostate cancer biochemical recurrence and specific death.
    Hum Pathol. 2023 Dec 28:S0046-8177(23)00258.
    PubMed     Abstract available

  4. NWANZE J, Teramoto Y, Wang Y, Miyamoto H, et al
    Clinical impact of perineural invasion encircled completely vs. incompletely by prostate cancer on needle core biopsy.
    Hum Pathol. 2023;143:71-74.
    PubMed     Abstract available

    August 2023
  5. WANG Y, Teramoto Y, Miyamoto H
    Comedonecrosis within conventional prostatic adenocarcinoma vs. intraductal carcinoma of the prostate: their clinical significance is not comparable.
    Hum Pathol. 2023;138:112-120.
    PubMed     Abstract available

    May 2023
  6. LEMSTER AL, Anika W, Justus B, Sven P, et al
    Elevated PSPC1 and KDM5C Expression indicates Poor Prognosis in Prostate Cancer.
    Hum Pathol. 2023 May 18:S0046-8177(23)00118.
    PubMed     Abstract available

  7. OKUBO Y, Sato S, Hasegawa C, Koizumi M, et al
    Cribriform pattern and intraductal carcinoma of the prostate can have a clinicopathological impact, regardless of their percentage and/or number of cores.
    Hum Pathol. 2023;135:99-107.
    PubMed     Abstract available

    March 2023
  8. TEKIN B, Dasari S, Theis JD, Vrana JA, et al
    Mass Spectrometry-Based Assessment of Prostate Cancer-Associated Crystalloids Reveals Enrichment for Growth & Differentiation Factor 15 (GDF15).
    Hum Pathol. 2023 Mar 9:S0046-8177(23)00050-3. doi: 10.1016/j.humpath.2023.
    PubMed     Abstract available

  9. ABDULFATAH E, Fine SW, Lotan TL, Mehra R, et al
    Reprint of: de novo neuroendocrine features in prostate cancer.
    Hum Pathol. 2023 Mar 7:S0046-8177(23)00037-0. doi: 10.1016/j.humpath.2023.
    PubMed     Abstract available

  10. COLLINS K, Cheng L
    Reprint of: morphologic spectrum of treatment-related changes in prostate tissue and prostate cancer: an updated review.
    Hum Pathol. 2023;133:92-101.
    PubMed     Abstract available

    December 2022
  11. BAKBAK H, Sayar E, Kaur HB, Salles DC, et al
    Clonal relationships of adjacent Gleason pattern 3 and Gleason pattern 5 lesions in Gleason Scores 3+5=8 and 5+3=8.
    Hum Pathol. 2022;130:18-24.
    PubMed     Abstract available

  12. LIN X, Shi Q, Yang XJ
    Cytomorphology, immunoprofile, and clinicopathologic correlation of metastatic prostatic carcinoma.
    Hum Pathol. 2022;130:36-46.
    PubMed     Abstract available

    October 2022
  13. ZHAO T, Chuang HW, Cornejo KM, Crotty RK, et al
    Mucinous adenocarcinoma of the prostatic urethra after brachytherapy for prostatic adenocarcinoma: a case series.
    Hum Pathol. 2022;128:101-109.
    PubMed     Abstract available

    July 2022
  14. ABDULFATAH E, Fine SW, Lotan T, Mehra R, et al
    De Novo Neuroendocrine Features in Prostate Cancer.
    Hum Pathol. 2022 Jul 7. pii: S0046-8177(22)00175.

    June 2022
  15. COLLINS K, Cheng L
    Morphologic spectrum of treatment-related changes in prostate tissue and prostate cancer: An Updated Review.
    Hum Pathol. 2022 Jun 15. pii: S0046-8177(22)00149.
    PubMed     Abstract available

    February 2022
  16. RUDER S, Gao Y, Ding Y, Bu P, et al
    Development and Validation of a Quantitative Reactive Stroma Biomarker (qRS) for Prostate Cancer Prognosis.
    Hum Pathol. 2022 Feb 14. pii: S0046-8177(22)00033.
    PubMed     Abstract available

    January 2022
  17. SURESH N, Teramoto Y, Goto T, Wang Y, et al
    Clinical significance of perineural invasion by prostate cancer on MRI-targeted biopsy.
    Hum Pathol. 2022 Jan 18. pii: S0046-8177(22)00013.
    PubMed     Abstract available

    November 2021
  18. COLLINS K, Brocken E, Bahler CD, Alabd A, et al
    High Intensity Focused Ultrasound for the Treatment of Prostate Cancer: Assessing Location of Failure after Focal Therapy in Prostate Cancer and Review of Histological Characteristics and Clinicopathologic Correlates after Treatment: A 5-Year Experien
    Hum Pathol. 2021 Nov 18. pii: S0046-8177(21)00194.
    PubMed     Abstract available

  19. WU CL, Kim M, Wu S, Lin SX, et al
    Transperineal multiparametric magnetic resonance imaging-ultrasound fusion-targeted prostate biopsy combined with standard template improves perineural invasion detection.
    Hum Pathol. 2021;117:101-107.
    PubMed     Abstract available

    September 2021
  20. CHEN Z, Pham H, Abreu A, Amin MB, et al
    Prognostic value of cribriform size, percentage, and intraductal carcinoma in Gleason Score 7 prostate cancer with Cribriform Gleason Pattern 4.
    Hum Pathol. 2021 Sep 17. pii: S0046-8177(21)00163.
    PubMed     Abstract available

    July 2021
  21. OFFERMANN A, Joerg V, Hupe MC, Becker F, et al
    CDK19 as a diagnostic marker for high-grade prostatic intraepithelial neoplasia.
    Hum Pathol. 2021 Jul 24. pii: S0046-8177(21)00128.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Prostate Cancer is free of charge.